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Abstract
 
Common lymphoid progenitors (CLP) are generated in adult bone marrow (BM), but the in-
termediate steps leading to T cell commitment are unknown, and so is the site at which this
commitment occurs. Here, we show that colonies arising in the spleen 12 days after BM injec-
tion harbor T cell precursors that are undetectable in BM. These precursors did not generate
myeloid cells in vivo but repopulated the thymus and the peripheral T cell compartment much
faster than did CLP. Two lineage negative (Lin
 
 
 
) subpopulations were distinguished, namely
CD44
 
 
 
 Thy1
 
 
 
 cells still capable of natural killer generation and transient low-level B cell gen-
eration, and T cell–restricted CD44
 
 
 
 Thy1
 
 
 
 cells. At a molecular level, frequency of CD3
 
 
 
and preT
 
 
 
 mRNA was very different in each subset. Furthermore, only the CD44
 
 
 
 Thy1
 
 
 
subset have initiated rearrangements in the T cell receptor 
 
 
 
 locus. Thus, this study identifies
extramedullary T cell progenitors and will allow easy approach to T cell commitment studies.
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Introduction
 
Adult bone marrow (BM)
 
*
 
 contains hematopoietic stem
cells (HSCs) that can give rise to all lineages of blood cells
(1). Purified HSCs isolated from mice have been arranged
hierarchically according to the gradual loss of self-renewal
capacity (2, 3). The multipotent progenitor (MPP) pool can
be divided into long-term self-renewing HSC, short-term
self-renewing HSCs, and non-self-renewing MPPs (3). The
productive life span of a stem cell is probably related to its
self-renewal capacity, even though stochastic factors such as
nonspecific homing of injected cells and interactions with
certain environments may influence its survival.
Most HSCs were thought to differentiate first into lin-
eage-committed common lymphoid (CLP) or common
myeloid progenitors which subsequently generated mature
lymphoid- and myeloid-lineage populations (4–6). How-
ever, a common B cell/macrophage precursor has recently
been isolated, suggesting that other differentiation pathways
exist (7). In adults, progenitor differentiation occurs princi-
pally within BM, but precursor cells may have to migrate
elsewhere to complete their development (8). This is the
case of T cell precursors.
It is not yet known where and when CLP commitment
to T cell differentiation occurs. Hours after intravenous
grafting of BM cells into whole body–irradiated recipients,
rare donor-type cells are detected in the recipient thymus
(9, 10). These cells, however, are not capable of immediate
expansion: a progeny is only detected 2 wk later (8). This
lag period has been considered necessary for the seeding
and differentiation of donor BM in order to generate
committed precursors capable of thymus reconstitution. It
is usually assumed that this differentiation process takes
place in the host BM, but the possibility remains that T cell
commitment may require proliferation and differentiation
in other sites.
Indeed, after BM injection into irradiated hosts, donor-
type cells also migrate to spleen and generate colonies, as
first discovered by Till and McCulloch (11). Each spleen
colony is produced by the proliferation of a single stem cell,
or colony-forming unit (12). Proof of this clonal process
was provided by Wu et al. (13), who followed radiation-
induced karyotype modifications (14). Cells with an identi-
cal karyotype were later detected in the thymus and lymph
nodes, suggesting that these colonies contained precursors
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with lymphoid differentiation potential (15). We subse-
quently demonstrated that cells from individual day 12
spleen colonies (SC12) were capable of T and B lympho-
cyte generation and transient thymus reconstitution (16).
Collectively, these findings suggest that SC12 may contain
lymphoid-committed progenitors. The relationship be-
tween SC12 progenitors and BM progenitors is unknown.
It is possible that SC12 and BM progenitors have identical
characteristics. Alternatively, BM cell expansion in spleen
colonies may be accompanied by their differentiation and
the generation of progenitors with unique properties.
In this study, we compared the phenotypic and molecu-
lar characteristics of lineage-negative (Lin
 
 
 
) BM cells with
those of SC12 Lin
 
 
 
, and compared their potential for dif-
ferentiation in vivo and in vitro. Our results demonstrate
that SC12 Lin
 
 
 
 cells have unique properties and are a ma-
jor source of precursors committed to T cell differentiation.
 
Materials and Methods
 
Mice.
 
C57BL/6-Ly5.1 (Thy1.2) mice were purchased from
Transgenic Alliance (L’Arbresle, France) and CDTA (Orléans,
France). C57BL/6-Ly5.2 (Thy1.2) and C57BL/6-nu/nu (nude)
(Thy1.2, Ly5.2) mice were purchased from CERJ (Le Genest St.
Isles, France) and C57BL/6 CD3
 
 
 
/
 
 
 
-Ly5.1 (Thy1.2) from
CDTA. C57BL/Ba (Thy1.1, Ly5.2) and C57BL/6 recombina-
tion activating gene (Rag)2
 
 
 
/
 
 
 
-Ly5.1 mice were bred and main-
tained in the animal care facility at the Necker Institute (Paris,
France). 4–12-wk-old male and female mice were used.
 
Thymectomy.
 
C57BL/6 CD3
 
 
 
/
 
 
 
-Ly5.1 mice were anesthe-
tized and positioned on their back; an incision was made in the
skin above the sternum and the thymus removed with pincers.
The skin wound was closed with surgical metal clips.
 
Generation of SC12.
 
C57BL/6-Ly5.1 and thymectomized
(Tx) C57BL/6 CD3
 
 
 
/
 
 
 
-Ly5.1 hosts were exposed to lethal (950
rad) whole-body irradiation from a 
 
137
 
Cs source and maintained
on water containing antibiotics (neomycin sulfate 1 g/500 ml) for
1 wk. C57BL/Ba BM cells (6 
 
 
 
 10
 
4
 
) were then injected intrave-
nously via the retroorbital sinus. For generation of SC12 in nude
hosts, mice received a sublethal dose of 800 rad and 18 
 
 
 
 10
 
4
 
 BM
cells intravenously from C57BL/6-Ly5.1 donors. After 12 d, the
recipients’ spleens were removed and individual spleen colonies
were excised and pooled for subsequent studies.
 
Antibodies, Flow Cytometry, and Cell Sorting.
 
The following
mAbs were used for flow cytometry and/or cell sorting: anti-
CD3
 
 
 
 (145–2C11; BD PharMingen); anti-CD4 (RM4–5; BD
PharMingen); anti-CD5 (53–7.3); anti-CD8
 
 
 
 (53–6.7; BD
PharMingen); anti-CD11b/Mac-1 (M1/70; CALTAG); anti-
CD19 (1D3; BD PharMingen); anti-CD24/HSA (M1/69; BD
PharMingen); anti-CD16/CD32 (2.4G2); anti-CD34 (RAM34;
BD PharMingen); anti-CD43 (S7); anti-CD44 (1D7; BD Phar-
Mingen); anti-CD90.1/Thy1.1 (HO22.1); anti-CD45.2/Ly5.2
(104–2.1); anti-CD45R/B220 (RA3–6B2; BD PharMingen);
anti-CD117/c-kit (2B8; BD PharMingen); anti-CD127/IL-7R
 
 
 
(B12–1; BD PharMingen); anti-NK1.1 (PK136; BD PharMin-
gen); anti-Sca-1 (E13–161.7; BD PharMingen); antierythroid
(TER119); anti-TSA1/Sca-2 (MTS35; BD PharMingen); anti–
TCR-
 
 
 
 (H57–597; BD PharMingen); and anti-V
 
 
 
2 (B20.1; BD
PharMingen). These antibodies were conjugated to biotin (re-
vealed by streptavidin-RED613 (GIBCO BRL) or streptavidin-
APC (BD PharMingen)), FITC, APC, PE, and PerCP for four-
color analysis and cell sorting. Flow cytometry and cell sorting
were performed on a FACSCalibur™ (Becton Dickinson) and a
FACSVantage™ (Becton Dickinson), respectively.
For analysis of SC12 populations, cells were first incubated
with an unconjugated rat antibody (Ter119) specific for the
erythroid marker. Erythroid cells were removed with sheep anti–
rat IgG-conjugated beads (Dynabeads M-450; Dynal A.S.) and
the remaining cells were labeled with antibodies recognizing
Ly5.2 (donor population) and lineage (Lin) antigens (CD3,
CD19, Mac-1, NK1.1, and TCR-
 
  
 
). Ly5.2
 
 
 
 Lin
 
 
 
 cells repre-
sented 
 
 
 
5–8% of such depleted populations.
Other single-cell suspensions were stained with mAbs as indi-
cated in figure legends. Dead cells were excluded by size and
structural characteristics. Data were analyzed with CellQUEST™
software (Becton Dickinson).
 
In Vivo Transfer of Precursor Cells.
 
Host mice were irradiated
(600 rad) and precursor cells were injected intrathymically or in-
travenously. Intrathymic injections were performed as described
elsewhere (16). Briefly, 3 h after irradiation, 4–5-wk-old C57BL/
6-Ly5.2 mice were anesthetized and positioned on their backs; a
small incision (
 
 
 
5 mm) was made in the skin above the sternum.
Cells were injected into one thymic lobe in a 20-
 
 
 
l volume using
a Hamilton syringe. The skin wound was closed with surgical
metal clips.
Donor T cells were recovered from lymph nodes, spleen and
BM of hosts reconstituted by intravenous transfer (sublethally ir-
radiated C57BL/6 Rag2
 
 
 
/
 
 
 
-Ly5.1 mice). The lymph nodes sam-
pled were the pooled axillary, inguinal, and mesenteric nodes, es-
timated to represent approximately half the total body lymph
node mass (17). BM recovery was calculated based on the as-
sumption that two femora and two tibiae represent 25% of total
BM (18). Consequently, the size of the T cell pool was calculated
with the following formula: 2
 
 
 
LN
 
 
 
1
 
 
 
Spleen
 
 
 
4
 
 
 
BM (LN,
number of donor T cells in collected lymph nodes; Spleen, num-
ber of donor T cells collected in spleen; BM, number of donor T
cells collected in two femora and two tibiae).
The number of NK cells was calculated with the following
formula: Spleen
 
 
 
4
 
 
 
BM (Spleen: number of donor NK cells
collected in spleen; BM: number of donor NK cells collected in
two femora and two tibiae).
 
In Vitro Colony-forming Assay.
 
After pretreatment, total
CFU-C were quantified in Complete Methylcellulose Medium
with Recombinant Cytokines and Erythropoietin (MethoCult
M3434; StemCell Technologies, Inc.) or in MethoCult M3230
routinely supplemented with optimal concentrations of murine
recombinant IL-3 (1 ng/ml), stem cell factor (SCF 100 ng/ml),
IL-6 (100 U/ml) and erythropoietin (2 U/ml). Sorted cell popu-
lations were plated in a final volume of 1 ml at densities ranging
from 0.2–5 
 
 
 
 10
 
5
 
 cells per culture dish (FALCON 1008). Colo-
nies were scored on day 7–8.
 
TCR Gene Rearrangements.
 
Cells were lysed by freezing the
pellet to –80
 
 
 
C, followed by heating to 95
 
 
 
C for 10 min in 10 
 
 
 
l
of H
 
2
 
0/100,000 cells. 1 
 
 
 
l of proteinase K (10 mg/ml/100,000
cells) was added and each sample was incubated for 30 min at
65
 
 
 
C, followed by 10 min at 95
 
 
 
C. All PCR runs were per-
formed with equalized samples (as determined by C
 
 
 
 quantifica-
tion in non saturating conditions with 30 amplification cycles) on
an average of 10
 
4
 
 cells. TCR-
 
 
 
 chain DJ and V(D)J rearrange-
ments were analyzed by using PCR primers in previously de-
scribed conditions (19, 20). VJ
 
 
 
 rearrangements were amplified
by using two 5
 
 
 
 primers recognizing, respectively, the 
 
V
 
 
 
2
 
 gene
and the 
 
V
 
 
 
5
 
 gene, and one 3
 
 
 
 primer recognizing the 
 
J
 
 
 
1
 
 gene.
Primers and probes were a gift from P. Pereira (Pasteur Institute, 
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Paris, France). V
 
 
 
-J
 
 
 
 rearrangements were studied as described
previously (21). The amplification products were analyzed on
1.5% agarose gel and visualized by ethidium bromide staining.
 
RT-PCR.
 
Limiting numbers of Lin
 
 
 
 cells were sorted using
a FACSVantage™ flow cytometer equipped with an automatic
cell deposition unit (Becton Dickinson). RT-PCR analysis was
performed as described previously (22). Briefly, cells in each well
were lyzed, mRNAs coding for the genes of interest were re-
verse-transcribed using specific 3
 
 
 
 primers, and cDNAs were am-
plified in a modified nested two-step PCR procedure. Plating ef-
ficiency was determined by the simultaneous amplification of the
mRNA coding for the house keeping gene HPRT.
RT primers were: CD3
 
 
 
: 5
 
 
 
-GATGGCTCATAGTC-
TGGGTT-3
 
 
 
; GATA-2: 5
 
 
 
-GGTGACTTCTCTTGCATG-
CACTT-3
 
 
 
; HPRT: 5
 
 
 
-TCCAACACTTCGAGAGGTCC-3
 
 
 
;
Pax5: 5
 
 
 
-TGATCCTGTTGATGGAGCTG-3
 
 
 
; and preT
 
 
 
: 5
 
 
 
-
CCTGGGCTTTGTTCTTCCTG-3
 
 
 
. For the first PCR, 5
 
 
 
primers were: CD3
 
 
 
: 5
 
 
 
-ACCAGTGTAGAGTTGACGTG-3
 
 
 
;
GATA-2: 5
 
 
 
-TTCTTCTGCAGGGGGTAGTGTAG-3
 
 
 
; HPRT:
5
 
 
 
-GGGGGCTATAAGTTCTTTGC-3
 
 
 
; Pax5: 5
 
 
 
-AGGAC-
ATGGAGGAGTGAATC-3
 
 
 
; preT
 
 
 
: 5
 
 
 
-AACAGGTAGCTC-
CTGGCTGCA-3
 
 
 
. For CD3
 
 
 
, GATA-2, HPRT, Pax5, and
preT
 
 
 
, 3
 
 
 
 primers were the same as for the RT reaction. For
the second PCR, 5
 
 
 
 primers were: CD3
 
 
 
: 5 -TTTCTCGGA-
AGTCGAGGACA-3 ; GATA-2: 5 -GACTATGGCAGCA-
GTCTCTTCC-3 ; HPRT: 5 -GTTCTTTGCTGACCTG-
CTGG-3 ; Pax5: 5 -TTTGTGAATGGACGGCCACT-3 ;
preT : 5 -GCGTCAGGTGTCAGGCTCTA-3 ; 3  primers
were: CD3  and Pax5 (same primer as for the RT reaction);
GATA-2: 5 -GGTGGTTGTCGTCTGACAATT-3 ; HPRT:
5 -TGGGGCTGTACTGCTTAACC-3 ; and preT : 5 -GAG-
CAGTAGTGTCCAGCATC-3 . None of the primer combina-
tions amplify genomic DNA. The amplification products were
analyzed on 1.5% agarose gel and visualized by ethidium bromide
staining.
The interpretation of our data depends on the sensitivity of
our RT-PCRs assessed by several approaches. First, we always
tested plating efficiency, by HPRT amplification. Second, we
compared the relative efficiency of our RT-PCRs, by determin-
ing the slopes of PCR product accumulation with different cy-
cles, in nonsaturating conditions using real time PCR (Taqman;
Perkin Elmer). We found that the slopes were parallel, indicat-
ing similar efficiency. These results indicate that the message for
each gene should be amplified when expressed at the same fre-
quency as HPRT (the calculated number of HPRT mRNA
molecules/cell is 5–10; reference 23). Finally, we studied indi-
vidual cells known to express these different genes: Pax5 (B lym-
phocytes); CD3  (T lymphocytes); and preT  (the TCR- 
transfected SCID thymocyte cell line SCB29; reference 24). We
could amplify these genes in all individual cells studied. In
CD44  CD25  TN thymocytes, 96% expressed CD3  mRNA
and 75% preT  mRNA (25). To determine frequencies, we
used a wide range (from 1 to 1,000) of cell numbers (Table I). As
frequency estimates can only be calculated when negative and
positive wells are present, the cell concentrations we used to cal-
culate frequencies varied according to the population and the
gene studied (Table I).
Results
Characterization of the Lin  Population in SC12. To
generate spleen colonies, we injected 6   104 syngeneic
Ly5.2  BM cells from C57BL/Ba mice into lethally irradi-
ated C57BL/6-Ly5.1 host mice. Using these experimental
conditions, 6–8 colonies were formed on the spleen surface
12 d later; these colonies were nonconfluent and each con-
tained an average of 107 cells. The majority of SC12 cells
were erythroid (Ly5.2  Ter119 ), but specific depletion of
this population yielded  106 Ly5.2  donor cells per host.
We first compared the frequency of Lin  cells among
Ly5.2  cells from BM and SC12, using a cocktail of mAbs
recognizing the following differentiated cells: T cells (anti–
TCR-   and anti-CD3), B cells (CD19), NK cells
(NK1.1), and granulocytes and macrophages (Mac-1). As
described previously (26),  5% of Ly5.2  BM cells were
Lin . In contrast, 14.5   3.4% (n   17) of Ly5.2  SC12
donor cells were Lin .
We then compared the characteristics of these Lin  cells
derived from BM and SC12. SC12 Lin  cells were, on av-
erage, larger than their BM counterparts (Fig. 1 A). CD16/
CD32, CD34, AA4.1 (data not shown), and IL-7R  (Fig.
1 B) expression was similar in the two populations. The
frequency of c-kit, Sca-2, and CD5-expressing cells was
higher in SC12 than in BM Lin  cells, but most cells ex-
pressed less of these molecules, when compared with the
high expressing BM population. Most SC12 cells were Sca-
1 , and Sca-1high populations were much more abundant as
compared with BM Lin  cells (Fig. 1 B). BM and SC12
Lin  cells also differed by their B220, CD43, HSA,
Thy1.1, and CD44 expression (Fig. 1 B from left to right).
Most BM Lin  cells expressed B220 antigen (a marker of B
and NK cell precursors; reference 27), while most SC12
Lin  cells were B220 . CD43high and HSAhigh cells, corre-
sponding to markers of pro-T cells (5), were very rare
among the BM Lin  but frequent among SC12 Lin  cells.
Thus, SC12 Lin  cells appeared to be enriched in T cell–
committed precursors relative to BM Lin  cells. Thy1.1 
cells were rare in the BM Lin  subset, and most of them
Table I. Cell Densities (Cells per Well) Used for the Limiting Dilution RT-PCR Analysis
BM Lin  cells SC12 Lin  CD44  cells SC12 Lin  CD44  cells
GATA-2 1 100, 10, 5 100, 10, 5
Pax5 500, 50 1,000, 50, 10 1,000, 500, 200
CD3  500, 200, 100 200, 100, 50 1
pre-T  1,000 200, 100, 50 100, 10, 5922 T Cell–restricted Precursors in Spleen Colonies
were Thy1.1low. In contrast about half of SC12 Lin  cells
were Thy1.1high. Besides, SC12 Lin  cells contained a
CD44  population, that was not found in BM Lin  subset.
Expression of CD44 and Thy1.1 antigens allowed to
identify two major subsets of SC12 Lin  cells. About half
were CD44  Thy1.1high (Fig. 1 C), a phenotype virtually
absent among BM Lin  cells (Fig. 1 C). In contrast, the
SC12 CD44  population did not express Thy1.1, while vir-
tually all Thy1.1  cells in the BM were CD44  (Fig. 1 C).
Thus, SC12 Lin  cells were very different from BM
Lin  cells. Their phenotype suggested a marked enrich-
ment in T cell precursors. SC12 Lin  cells could be subdi-
vided into a discrete CD44  Thy1.1high population and a
CD44  Thy1.1  population.
Gene Expression in SC12 Lin  CD44  and CD44  Sub-
sets. To assess the lineage commitment of SC12 Lin 
CD44  and CD44  subpopulations relative to BM Lin 
cells, we determined the frequency of expression of the
following genes: GATA-2, encoding a transcription factor
involved in the expansion of early MPPs before lymphoid
commitment (28); Pax5, encoding a factor required for B
cell differentiation (29); CD3 , which is expressed by
preT cells, before TCR gene rearrangement (30); and
preT , encoding an essential component of the preTCR
(24, 31, 32).
The three populations were purified by two consecutive
sorting steps. The frequency of gene expression was evalu-
ated by the limiting dilution method. The frequency esti-
mates were calculated according to the Poisson distribution
(33). These methods are able to amplify as few as 1 mRNA
molecule/cell (22). Expression of these genes in BM Lin 
and SC12 Lin  populations are shown in Table II.
Half the BM Lin  population was GATA-2 mRNA-
positive, reflecting the abundance of uncommitted progen-
itors. Pax5 was expressed by 1.6% of cells and CD3  ex-
pression was rare (0.2%). Pre-T  mRNA transcripts were
not detected in the 8   103 cells studied. As regards the
SC12 Lin   CD44  and CD44   populations, GATA-2
mRNA expression was much lower than that observed in
the BM Lin  population, only 15.6% of CD44  cells and
6.7% of CD44- cells expressing GATA-2 mRNA. Pax5 ex-
pression was also very low (0.2% of CD44  cells and 0.04%
of CD44  cells). Moreover, the SC12 Lin  CD44  popu-
lation contained 1.6% of CD3  mRNA-expressing cells
and rare preT -positive cells. In contrast, almost all cells of
the SC12 Lin  CD44  subset expressed CD3  mRNA,
and 7.6% of cells expressed preT  mRNA.
We then analyzed TCR gene rearrangements (Fig. 2).
TCR-  locus rearrangements were absent among SC12
Lin  CD44  cells (Fig. 2 A). The V 2-J 1 rearrangement
was detected but rare (Fig. 2 B). TCR-  D-J rearrange-
ments had clearly taken place among SC12 Lin  CD44 
cells, as the DJ germline band was virtually absent and mul-
tiple D-J  rearrangement bands were present (Fig. 2 A).
TCR-  V-(D)J rearrangements were rare (Fig. 2 A), while
V 2-J 1 and V 5-J 1 rearrangements were abundant (Fig.
2 B). We detected no rearrangements of the TCR-  locus
in SC12 Lin  CD44  or CD44  cells (Fig. 2 B).
Collectively, these data indicated that the SC12 Lin 
CD44  population almost exclusively contained preT
Figure 1. Comparative analy-
sis of surface antigen expression
among BM Lin  and SC12 Lin 
populations. BM and SC12 cell
suspensions were labeled with
antibodies recognizing Ly5.2
(donor population) and lineage
antigens (CD3, CD19, Mac-1,
NK1.1, and TCR-  ). Results
show the Ly5.2  Lin  gated
populations, the dotted-lined
histogram representing control
isotype for anti-IL-7R  anti-
body, the thin-lined histograms
representing BM and the bold-
lined histograms SC12 cells. (A)
Forward scatter. (B) Differential
expression of cell surface anti-
gens. (C) Selective coexpression
of Thy1.1 antigen by SC12 and
BM Lin  CD44  and CD44 
populations. Fig. 1 shows one of
three independent experiments,
all yielding similar results.923 Lancrin et al.
cells, as 96% were CD3  mRNA  and TCR-  D-J and
TCR-  rearrangements were extensive. In contrast, few
SC12 Lin  CD44  cells expressed genes associated with
lymphoid commitment (Pax5, preT , CD3 ), and TCR
gene rearrangements were very rare. However, the low
GATA-2 expression in these cells suggested the loss of
pluripotent HSC activity (6). Thus, in vivo and in vitro
studies were designed to analyze lineage restriction in these
SC12 populations.
T Cell Potential of SC12 Lin  Subpopulations after Intrathy-
mic Transfer. To determine the capacity of SC12 Lin 
CD44  and CD44  cells to generate T cells in vivo relative
to BM Lin  cells, each population was isolated by fluores-
cence-activated cell sorting (FACS®), and 3   104 cells
from each subset were injected intrathymically into 600 rad
irradiated congenic C57BL/6-Ly5.2 (Thy1.2) recipient
mice. To study the presence and development of donor-
type cells, host thymuses were analyzed for the Thy1.1 do-
nor allotype and CD4/CD8 expression on days 7, 8, 11,
and 15 after injection (Fig. 3 and Table III).
All transferred Lin  populations were capable of T cell
generation but showed different kinetics of thymus recon-
stitution (Fig. 3). As previously reported, 1 wk after in-
jection, BM Lin  cells (top graphs) generated only
CD4 CD8  (DN) cells in the host thymus. On day 15,
CD4  CD8  (DP) cells were present at a normal frequency
but thymus reconstitution was not complete: the percent-
age of DN cells was increased, while the percentage of
CD4  CD8  (SP) cells was drastically reduced (only 1%),
as compared with the normal thymus (8%). Thymus recon-
stitution was more rapid after SC12 Lin CD44  injection
(middle graphs). On day 8 after transfer, DP cells repre-
Table II. Differential Expression of Developmental Genes in Precursor Populations
BM Lin  cells SC12 Lin  CD44  cells SC12 Lin  CD44  cells
% GATA-2 51.42a 15.60 (5.80) 6.70 (3.20)
% Pax5 1.60 (0.82) 0.19 (0.08) 0.04 (0.03)
% CD3  0.23 (0.13) 1.67 (0.55) 96b
% pre-T  Not detectedc 0.62 (0.20) 7.60 (3.40)
Lin  cells were sorted in limiting dilution conditions at two or three different cell densities per well (24 wells per density) and tested for GATA-2,
Pax5, CD3 , and pre-T  mRNA. The frequency estimates were calculated on wells which were scored positive by HPRT according to the Poisson
distribution (reference 33) and 95% confidence limits are shown in brackets. When the frequency of gene expression was high, individual cells were
sorted.
aThe frequency of GATA-2 mRNA expressing cells was estimated in 35 individual BM Lin  cells.
bThe frequency of CD3  mRNA expressing cells was estimated in 49 individual SC12 Lin  CD44  cells.
c8 wells containing 103 cells per well were analyzed to exclude pre-T  expression.
Figure 2. Analysis of TCR gene rearrangements in SC12
Lin  CD44  and CD44  subsets. Genomic DNA was ex-
tracted from sorted SC12 Lin  CD44  and CD44  cells,
and from a C57BL/6 spleen and a Rag-2 /  thymus. Each
sample (equivalent to 104 cells) was PCR-amplified, electro-
phoresed, and stained with ethidium bromide. (A) TCR- 
locus D-J (top) and V-(D)J (bottom) rearrangements. (B)
Analysis of V 2-J 1, V 5-J 1, and V -J  rearrangements.
Negative control (no DNA). Fig. 2 shows one of three inde-
pendent experiments yielding similar results.924 T Cell–restricted Precursors in Spleen Colonies
sented 50% of donor cells, and thymus regeneration was
complete on day 15 (DN cells were rare and SP cells were
present at a normal frequency). Thymus reconstitution af-
ter SC12 Lin  CD44  cell injection was even more rapid
(lower graphs). On day 7 after transfer the majority of do-
nor cells were DP, thymus reconstitution was complete by
day 11, and no donor-type cells were recovered in the thy-
mus on day 15.
The expansion of donor cells in the host thymus was also
evaluated (Table III). At day 11, the SC12 Lin  subsets
generated a larger progeny than BM Lin  cells. However,
the SC12 Lin  CD44  population had a lower expansion
capacity. At day 15, only SC12 Lin  CD44  and BM Lin 
cells still expand (Table III).
These results further supported the notion that SC12
Lin  CD44  cells contained a precursor population capable
Figure 3. Kinetics of thymus reconstitution after intrathymic transfer. C57BL/6-Ly5.2 (Thy1.2) mice were sublethally irradiated, injected intrathymi-
cally with 3   104 Lin  cells from the BM, SC12 CD44  and CD44  subpopulations, and studied 7, 8, 11, and 15 d after intrathymic transfer. Fig. 3
shows the CD4/CD8 expression of donor-type (Thy1.1 ) thymocytes in one of two independent experiments yielding similar results.
Table III. Accelerated Thymic Repopulation after Intrathymic Transfer of SC12 Lin  CD44  and CD44 
Transferred populationsa
Injected cells
(  10 4) Recovered donor-type thymocytes (  10 4) Ratio of recovered/injected
11 d after transfer
BM Lin  4.3 2   0.5b (n   3) (1.6–3)c 0.46
SC12 Lin CD44  3.2 30   23.1b (n   3) (2.4–79)c 9.4
SC12 Lin CD44  2.9 14   5.3b (n   6) (1.1–29)c 4.8
15 d after transfer
BM Lin  2.5 396   161.6b (n   3) (75–595)c 158
SC12 Lin CD44  2.6 210   14.7b (n   7) (49–1,100)c 80
SC12 Lin CD44  2.6  0.001 (n   6)  0.001
aBM and SC12 Ly5.2+ Lin  populations were sorted and transferred intrathymically to congenic donors. At the indicated times, the thymus was re-
moved and scored by FACS® analysis for the donor-type Thy1 allotype.
bMean of recovered donor-type thymocytes   SEM.
cRange of repopulation (min.–max.). n   number of mice.925 Lancrin et al.
of very rapid thymus reconstitution but with limited self-
renewal capacity. Surprisingly, the SC12 Lin  CD44 
population (which showed no obvious molecular evidence
of T cell commitment, Table II) also repopulated the thy-
mus more rapidly than did BM Lin  cells.
Hematopoietic Potential of SC12 Lin  Populations. To
fully test the capacity of SC12 Lin  CD44  and CD44 
cells to generate hematopoietic lineages, each population
(4   104 cells) was grafted intravenously into 600 rad irra-
diated Rag2 / -Ly5.1 recipient mice. The T, B, NK, and
myeloid-generating potential of these precursors was evalu-
ated 14 and 28 d after transfer.
Both SC12 populations colonized and reconstituted the
thymus (Fig. 4 A). In mice having received SC12 Lin 
CD44  cells, the DP compartment was fully reconstituted
14 d after injection, but SP cells were not detected. In con-
trast, in mice having received SC12 Lin  CD44  cells,
both the DP and SP compartment were reconstituted 14 d
after transfer. Both SC12 Lin  populations induced a rapid
and transient thymus colonization, as DP thymocytes were
no longer detected at 28 d after injection (Fig. 4 A).
Analysis of the peripheral compartment (Fig. 4 B) 1 mo
after transfer of SC12 Lin  cells revealed that mature T cells
were recovered from the spleen (Fig. 4 B), the lymph
nodes (data not shown) and the BM (Fig. 4 C). The num-
ber of these T cells was about half to two thirds of that
found in normal mice.
Most mature cells generated in mice having received
SC12 Lin  CD44  cells were T lymphocytes (Fig. 4 B,
left).   5% of donor cells, however, were TCR-   
CD4  CD8  (Fig. 4 B, left): this population contained
CD19  cells that, once gated expressed B220 and IgM an-
tigens (Fig. 4 B, right). This B cell generation was transient,
as we could not detected B cells 2 mo after transfer (data
not shown). SC12 Lin  CD44  cells also generated NKT
lymphocytes and NK cells in the spleen (data not shown)
and BM (Fig. 4 C, Table IV). In contrast, in mice injected
with SC12 Lin  CD44  cells no B cell progeny was de-
tected (Fig. 4 B and Table IV). We also failed to detect
NKT cells or NK cells in the spleen (data not shown). A
very small number of NK1.1  cells was visualized in the
BM (Fig. 4 C, Table IV).
To study myeloid potential of SC12 populations, they
were transferred to sublethally (600 rad) irradiated Rag2 / 
mice. This model was described as optimal for determin-
ing the myeloid potential of Lin  populations, because en-
dogenous irradiated BM was poorly competitive (5).
When these hosts were injected with 4   104 BM Lin 
cells, we generated 7   106 myeloid cells in the host, 1 mo
later (data not shown). In contrast, the same number of
SC12 Lin  CD44  or CD44  progenitors, did not engen-
der any myeloid cells after transfer (data not shown). This
myeloid differentiation might not have occurred because
of low precursor frequencies or we may have failed to de-
tect a transient production by committed precursors with
reduced self-renewal capacity. To circumvent these limita-
tions, we also evaluated myeloid differentiation in vitro, in
the presence of a cocktail of growth factors supporting op-
timal myeloid colony formation. Both the SC12 Lin 
CD44  and CD44  subsets generated rare myeloid colo-
nies in methylcellulose: 1/33 myeloid precursors in the
BM Lin  population, versus 1/166 in the SC12 Lin 
CD44  population and 1/1,450 in the SC12 Lin CD44 
population (in one of two independent experiments giving
similar results).
Thus, the SC12 Lin  CD44  and CD44  populations
have different differentiation potentialities. The most im-
mature population, CD44 , mainly generates T cells and
Figure 4. In vivo development of SC12 Lin  CD44  and CD44  populations after intravenous transfer. SC12 Lin  CD44  and CD44  cells (4  
104) were injected intravenously into 600 rad irradiated Rag2 / -Ly5.1 recipient mice, and studied 14 and 28 d after transfer. Results are from one of
three independent experiments performed with similar results. Analysis of CD4/CD8 expression of donor-type (Ly5.2 ) cells in: (A) the thymus. Both
precursor subsets gave only transient thymic repopulation; (B, left) the spleen, 28 d after transfer. (B, right) Analysis of B cell reconstitution in the spleen
of recipient mice 28 d after transfer of SC12 Lin  CD44  and CD44  cells. Donor Ly5.2  CD19  cells were gated and tested for B220 and IgM ex-
pression. No B cells were detected in the periphery of CD44  chimeric mice. (C) Analysis of NK cell reconstitution in the BM of recipient mice 28 d
after transfer of SC12 Lin  CD44  and CD44  cells. Donor cells were gated and tested for TCR-  and NK1.1 expression. Rare NK cells are present in
the BM of CD44  chimeric mice.926 T Cell–restricted Precursors in Spleen Colonies
NK cells. Some B cells are transiently produced. In con-
trast, CD44  cells produce T cells more rapidly, yield no
B cells and very rare NK cells or NKT cells, that can only
be visualized in the BM. Neither population generates
myeloid cells in vivo. Some myeloid precursors were
detected in vitro, but they were quite rare (in SC12
Lin CD44  cells in particular) and may have limited self-
renewal capacity.
T Cell Potentiality in SC12 Populations Is Independent of the
Thymus. To determine whether the thymus is necessary
for the generation of SC12 Lin  populations, spleen colo-
nies were generated by injection of BM into Tx C57BL/6
CD3 / -Ly5.1 or into nude hosts. In both recipients,
SC12 colonies had the same size, and Lin  CD44  and
CD44  subsets were present at the same frequency as
found in euthymic hosts (data not shown). Analysis of
TCR-  locus rearrangements (D-J and V-DJ) were per-
formed in SC12 Lin  CD44  and CD44  subsets pro-
duced in athymic mice. Fig. 5 A indicates that TCR-  lo-
cus rearrangements were absent among SC12 Lin  CD44 
while TCR-  D-J and V-DJ rearrangements had clearly
taken place among SC12 Lin  CD44  cells. These molec-
ular characteristics are similar to those of SC12 Lin  cells
generated in euthymic mice (Fig. 2 A).
To evaluate the capacity of thymus reconstitution, SC12
Lin  subpopulations, generated in euthymic and athymic
mice were sorted, and injected side by side intrathymically.
As shown in Fig. 5 B, we found no differences in the T cell
differentiation potential of SC12 Lin  CD44  and CD44 
subsets generated in Tx hosts, as compared with those gen-
erated in euthymic mice. Altogether, these data demon-
strate that the thymus is not necessary for the induction of
T cell commitment in SC12 progenitors.
Discussion
These results show that Lin  populations from day-12
spleen colonies and BM are very different. First, their over-
all phenotype is different. The frequency of c-kit, Sca-2,
and CD5 expressing cells was higher in SC12 than in BM
Lin  cells, but most cells expressed less of these molecules,
when compared with the high expressing BM cells. The
Lin  CD44  Thy1.1  population could not be detected in
the BM. The SC12 Lin  CD44  population differed by
other cell surface markers from BM CD44  population.
Second, the frequency of SC12 Lin- cells expressing
GATA-2 mRNA, a marker of multipotent precursors, is
lower than the frequency of GATA-2 mRNA-expressing
cells in BM Lin  population. In keeping with this observa-
tion, SC12 differentiation capacity was very restricted.
SC12 generated only rare myeloid cells, that could only be
detected by in vitro culture. Likewise, B and NK cell pro-
ductions were either very limited or absent. In contrast,
SC12 cells were a major source of T cell precursors. They
colonized the thymus much more rapidly than BM Lin 
cells and that the previously described CLP (5). Conse-
quently, the generation of mature T cells in these mice was
precocious. A substantial reconstitution of the peripheral T
cell pool was observed 1 m after transfer. At this latter time
point only rare mature T cells are detected in mice injected
with HSC (5).
We fractionated SC12 Lin  cells on the basis of CD44
antigen expression and found a discrete CD44  popula-
tion  that shared certain properties with CD44 CD4 
CD8 CD3  thymocytes (TN). In particular, SC12 Lin 
CD44  cells also expressed Thy1, and virtually all expressed
CD3  mRNA; TCR gene rearrangements (TCR-  and
TCR-  locus rearrangements) matched the pattern de-
scribed in CD44  TN thymocytes (34, 35). Overall, these
properties indicate that the SC12 Lin  CD44  population is
relatively advanced in T cell lineage commitment. Accord-
ingly, their differentiation potential was very restricted, as
they were only able to generate T cells and a few NK cells,
that could only be detected in the BM.
The properties of SC12 Lin  CD44  cells did not, how-
ever, fully overlap with those of TN cells. First, only 50%
of SC12 Lin CD44  cells expressed CD25 (data not
shown) while 65–85% of CD44  TN were CD25  (36,
37). Second, while 75% of CD44  CD25  TN thymocytes
expressed preT  mRNA and not GATA-2 mRNA (25),
only 7% of SC12 Lin CD44  cells expressed preT  and
6% expressed GATA-2 mRNA. This coexpression of
CD3  and GATA-2 mRNA by the same population is sur-
prising, and may correspond to priming stages at which oli-
golineage commitment remains flexible. It also supports
models of lineage commitment in which functionally re-
stricted populations may conserve the molecular machinery
of previous differentiation stages. Indeed, recent data indi-
cate that lymphoid commitment might proceed by down-
regulation of cytokine receptors that drive myeloid devel-
opment (38).
For the SC12 Lin  CD44  subset, molecular analysis
showed that TCR-  locus rearrangements were absent and
that only 1% of cells expressed CD3  mRNA. Therefore,
it was surprising that this population, with little molecular
Table IV. Repopulation of the Peripheral Lymphoid Compartment 
after I.V. Transfer of SC12Lin CD44  and CD44  Populations
SC12Lin  cells transferred
4   104 CD44  4   104 CD44 
Donor type cells (  10 4)TB a NKb TB N K b
Mouse 1 1380 12 32 493 - 0.6
Mouse 2 396 7 9.5 581 - 2.6
Results show the total numbers of T, B, and NK cells recovered from
lymph nodes, spleen, and BM in mice injected with SC12 Lin  cells, 28 d
after intravenous transfer.
aNo B cells were detected in the lymph nodes and BM of these mice.
bNo NK cells were detected in the lymph nodes of these mice.
 , B cells were not detected.927 Lancrin et al.
evidence of T cell differentiation, showed such restricted
differentiation potential and ample evidence of T cell com-
mitment. These results suggest that commitment may pre-
cede rearrangements of T cell–specific genes, as shown for
B cells (39). Indeed, SC12 Lin  CD44  generated rare my-
eloid cells in vitro, but we observed no myeloid potential
after intravenous transfer. This suggests that the SC12 Lin 
CD44  fraction contained few myeloid progenitors and/or
that these progenitors failed to colonize the appropriate en-
vironment, or that they lack self-renewal capacity. The
SC12 Lin  CD44  subset generated only rare B cells. This
production was also transient, as B cells were detected 1
mo after intravenous transfer but not subsequently. In con-
trast, the SC12 Lin  CD44  subset generated abundant
thymocytes, and substantial reconstitution of the peripheral
T cell pool was observed 1 mo after injection, a time when
very few T cells are detected after HSC injection (5). This
population also generates NK cells. The very limited B cell
generation, associated with major T cell production, sug-
gests that SC12 Lin  CD44  cells were more committed to
T cell differentiation than are CLP, that generates identical
numbers of T and B cells (5). This notion is reinforced by a
comparison of the kinetics of thymus reconstitution by the
two precursor populations. CLP take 3 wk to reconstitute
all thymocyte populations and thymic DP cells take 6 wk
to disappear (5). In contrast, after intravenous injection of
SC12 Lin  CD44  cells, all DP cells had disappeared by 4
wk after transfer.
We are currently investigating whether the rare my-
eloid/B cell precursors originate from a minor cell subset.
Figure 5. SC12 Lin  CD44  and CD44  subpopula-
tions generated in athymic mice. (A) SC12 were generated
by injection of BM into irradiated nude hosts. TCR-  lo-
cus D-J (top) and V-(D)J (bottom) rearrangements were
studied as described in Fig. 2. (B) 3   104 Lin  cells from
the SC12 CD44  and CD44  subpopulations generated in
euthymic mice (C57BL/6-Ly5.1, left) or in athymic mice
(Tx C57BL/6 CD3 / -Ly5.1, right) were injected in sub-
lethally irradiated C57BL/6-Ly5.2 (Thy1.2) hosts. Mice
receiving an injection of SC12 Lin  populations recovered
from athymic and euthymic recipients were studied simul-
taneously. Graphs show the CD4/CD8 expression of do-
nor-type thymocytes (Thy1.1 ) 10 d (SC12 Lin  CD44 )
and 13 d (SC12 Lin  CD44 ) after transfer.928 T Cell–restricted Precursors in Spleen Colonies
The conservation of multifunctional properties and tran-
sient repopulation capacities could also indicate that com-
mitment to a single lineage is in progress. Indeed, the rare
myeloid progenitors present in the SC12 Lin  CD44  sub-
set may not be representative of the major myeloid differ-
entiation pathway (6). Similarly, the restricted B cell gener-
ation may be due to the presence of a minor subset of
bipotent T-B progenitors.
Altogether, our results demonstrate a new source of T
cell progenitors with major advantages over BM Lin  and
CLP BM-derived cells. First, they are very easy to recover,
and can be obtained in much larger numbers. Unfraction-
ated SC12 Lin  population is very enriched in T cell–com-
mitted precursors, and can be recovered by easy depletion
of Lin  cells (5). Second, SC12 populations generate T
cells much more rapidly than do BM Lin  and CLP. Both
these characteristics make these progenitors ideal for pe-
ripheral T cell reconstitution. Therefore, it is possible that
such precursors may be of use in cell therapy, but this no-
tion is speculative at this stage. The identification of inter-
mediate stages of differentiation in between CLP and TN
thymocytes, however, will facilitate the identification of
the mechanisms leading to T cell commitment.
Concerning the origin of these precursors, the genera-
tion of SC12 cells in athymic mice indicate that these pro-
genitors do not transit through the thymus before coloniz-
ing the spleen. The relationship between the SC12
progenitors and BM precursors remains to be established.
The Lin  CD44  Thy1.1  population cannot be detected
in the BM. Only  0.08% of BM Lin  cells have this phe-
notype, but these BM cells have a different pattern of gene
expression (CD3  mRNA expression is rare and preT 
mRNA is not expressed; data not shown) in comparison
with SC12 Lin  CD44 . The distribution of different cell
surface markers in SC12 CD44  cells is also different from
that found in BM CD44  cells. SC12 CD44  cells resem-
ble CLP (5), by their absence of Thy1.1 and low expres-
sion of c-kit, but differ by their expression of IL-7R  and
Sca-1. SC12 populations may differentiate in situ from
more immature BM precursors. It cannot be excluded,
however, that SC12 may only represent the expansion of
minor populations already present in the BM but too rare
to be detected by available methods. Our results show,
however, that BM precursors undergo modifications in
the spleen. It is therefore possible that the extramedullary
environment is ideal for T cell precursor proliferation and/
or differentiation.
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